Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Turku University Hospital
Age
40–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age: 40 to 80 years
Language spoken: Finnish or Swedish
Performance status: Karnofsky score 70 or better or WHO performance status 2 or better
Diagnosis: Histologically confirmed prostate or breast cancer
Mental status: Patients must be able to understand the meaning of the study
Informed consent: The patient must sign the appropriate Ethics Committee (EC) approved informed consent documents in the presence of the designated staff
strong suspicion of first bone metastatic disease (already diagnosed metastases in other organs, elevated tumor markers, destruction of bone in plain x-ray or otherwise specified reasons
adjuvant chemo- or endocrine therapy is allowed
You may not be if
Ongoing treatment for metastatic disease
Contraindications for MRI (cardiac pacemaker, intracranial clips etc.)
Infections: Patient must not have an uncontrolled serious infection
Claustrophobia
Clareo Health | Imaging of Prostate and Breast Cancer Bone Metastases Using Magnetic Resonance Imaging and Nuclear Medicine Techniques
